• Chief Healthcare ExecutiveChief Healthcare Executive
  • Formulary WatchFormulary Watch
  • Managed Healthcare Executive
  • Medical EconomicsMedical Economics
Managed Healthcare Executive
Managed Healthcare Executive
Resource Centers
View MoreAsthmaAtrial FibrillationBiosimilarsBlood CancerCovid-19DermatologyDigital HealthEye CareHemophiliaHIVLiver DiseaseMultiple SclerosisPost-Acute CarePrescription Digital TherapeuticsRespiratory ConditionsSleep DisordersSubstance Use DisorderType II InflammationUlcerative ColitisVaccines
Spotlight
AMCP AnnualAsembia’s 2022 Specialty Pharmacy SummitAMCP NexusExamining Evolving Treatment Paradigms in the Hemophilia B Space Payer Provider Perspectives: Prescription Digital Therapeutics: Reimagining Care in Behavior-Driven ConditionsPBMI National ConferenceUnbranded Biologics: An Overview
Business
View MoreBusiness StrategyChronic DiseaseConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
ConferencesPartners
Publications
MHE Publication
Supplements And Featured Publications
Events
Virtual Events
CME/CE
Resources
PBM Leaders
Sponsored
Sponsored Content
Surveys
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations

© 2023 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

Advertisement
Resource CentersSee All >
  • Asthma
  • Atrial Fibrillation
  • Biosimilars
  • Blood Cancer
  • Covid-19
  • Dermatology
  • Digital Health
  • Eye Care
  • Hemophilia
  • HIV
  • Liver Disease
  • Multiple Sclerosis
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Respiratory Conditions
  • Sleep Disorders
  • Substance Use Disorder
  • Type II Inflammation
  • Ulcerative Colitis
  • Vaccines
Spotlight
  • AMCP Annual
  • Asembia’s 2022 Specialty Pharmacy Summit
  • AMCP Nexus
  • Examining Evolving Treatment Paradigms in the Hemophilia B Space
  • Payer Provider Perspectives: Prescription Digital Therapeutics: Reimagining Care in Behavior-Driven Conditions
  • PBMI National Conference
  • Unbranded Biologics: An Overview
BusinessSee All >
  • Business Strategy
  • Chronic Disease
  • Consumers
  • Drug Costs
  • Drug Pipeline
  • Formulary
  • Health Management
  • Health/Disease Strategy
  • Hospitals & Providers
  • Industry Analysis
  • Pharmacy
  • Politics and Policy
  • Practice Management
  • Reimbursement
  • Technology
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Opioids

  1. home
  2. clinical
  3. opioids
 

How COVID-19 Is Affecting Those with Opioid Use Disorder

December 02, 2020

As the world remains battling the coronavirus pandemic, there are still significant and unmet needs for those fighting chronic conditions and disorders like opioid use disorder (OUD).

FDA Updates: ALKS 3831 Wins Joint Panel Nod; Regeneron, Lilly Seek EUAs for Anti-COVID Antibodies

October 11, 2020

The PDUFA date for Alkermes' combination therapy is November 15, 2020.

3 Ways to Promote Telehealth During COVID-19 for Patients With Drug, Alcohol Addiction

July 04, 2020

The Financial Burden of the Opioid Epidemic

October 22, 2019

The opioid crisis cost the U.S. billions. Find out the impact on the future economy.

Surprising Findings About the Evolution of the Drug Epidemic

October 22, 2019

Despite the trust between physicians and patients, some physicians believe another prescription drug crisis may arise.

The Impact of Primary Care Appointment Times on Opioid Prescribing

October 15, 2019

A new study reveals that when physicians are under time constraints it can greatly impact their treatment decisions.  

Missing Data Masks Scale of Opioid Epidemic

September 27, 2019

Study shows a significant portion of overdoses in the U.S. mortality data is missing information on specific drugs involved.

Study to Assess State Policies Governing Opioid Use and Pregnancy

September 25, 2019

Information gleaned will be crucial to providers, insurers, and policy makers.

Blue Cross NC Invests in Addiction Treatment Provider

September 06, 2019

Up to 15 clinics are set to open nationwide in the next year.

The Link Between Opioid Overdose and Household Prescriptions

August 12, 2019

Individuals without their own prescriptions may be at risk for overdose if they have access to family members’ drugs, according to a new study

Advertisement
Advertisement